New heart stent shows promise in 888-Patient trial
NCT ID NCT06769217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug-coated stent called EvroSure in 888 people with blocked heart arteries. The stent releases medicine to keep the artery open and prevent future blockages. Researchers tracked major heart events like heart attacks or the need for repeat procedures at 30 days and 12 months to see if the stent is safe and works well.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baroda Heart Institute & Research Centre
Vadodara, Gujarat, 390007, India
-
Grandmed Lubuk Pakam Hospita
Tanjung Morawa, North Sumatra, Indonesia
-
Hospital (P) Ltd.
Kozhikode, Kerala, 673002, India
-
Medical College & Hospital
Bangalore, Karnataka, India
-
Primaya Tangerang
Jakarta, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Can a new heart pump outperform the standard during High-Risk angioplasty?
- AI reads blood flow to predict if heart stents will work
- Could a neck ultrasound replace heart CT scans for chest pain patients?
- Scoring balloon aims to crack tough heart plaques for better stent fit
- New balloon tackles tough heart blockages in major registry